You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • S35 Efficacy and safety of the direct switch from various previous treatments to glycopyrronium or indacaterol/glycopyrronium in patients with moderate copd: the crystal study

Article metrics

Article menu

Download PDFPDF

Beyond FEV1 in COPD
S35 Efficacy and safety of the direct switch from various previous treatments to glycopyrronium or indacaterol/glycopyrronium in patients with moderate copd: the crystal study
Free

 

Online download statistics by month:

Online download statistics by month: November 2016 to March 2024

AbstractFullPdf
Nov 20161703
Dec 20163103
Jan 2017158569
Feb 2017156035
Mar 2017114037
Apr 2017112050
May 2017126034
Jun 2017150043
Jul 2017164012
Aug 20176807
Sep 20178601
Oct 20176207
Nov 20177402
Dec 20176202
Jan 20187204
Feb 201810601
Mar 20182402
Apr 20186200
May 20185800
Jun 20184201
Jul 20184800
Aug 20184000
Sep 20182000
Oct 20183601
Nov 20186401
Dec 20183000
Jan 20192800
Feb 20193601
Mar 20192000
Apr 2019800
May 20191200
Jun 2019401
Jul 2019200
Aug 2019200
Sep 20191000
Oct 20191800
Nov 20191204
Dec 2019804
Jan 2020803
Feb 20201002
Mar 2020603
Apr 2020203
May 2020402
Jun 2020803
Jul 2020808
Aug 2020202
Sep 20201602
Oct 2020803
Nov 20201007
Dec 2020202
Jan 2021200
Feb 2021604
Mar 2021201
Apr 2021001
May 2021202
Jun 2021004
Jul 2021003
Aug 2021101
Sep 2021006
Oct 20212019
Nov 20210013
Dec 2021401
Jan 2022201
Feb 2022200
Mar 2022401
Apr 2022401
May 20224010
Jun 2022004
Jul 2022401
Aug 2022402
Sep 2022006
Oct 2022604
Nov 20224011
Dec 2022201
Jan 20230013
Mar 2023404
Apr 2023600
May 2023003
Jul 2023203
Aug 2023402
Sep 2023401
Oct 2023301
Nov 2023401
Dec 20231601
Jan 2024700
Feb 2024002
Mar 20244037
Total23355530